Apply Nuclear Medicine effectively in adults and become one of the most sought-after professionals in this area. Don't think twice and enroll in this specialization" 

The field of Nuclear Medicine is expanding. It is a discipline with numerous possibilities for growth, and one of its most innovative and booming avenues at present is its application to the adult population. This group of people has often been overlooked, because of their size no specific treatments are designed for them. 

For this reason, this Postgraduate Diploma in Nuclear Medicine in Adult Pathology is a great advance for those physicians who wish to specialize in order to provide the best response to the different pathologies that can be treated with it. Thus, this qualification offers its students the necessary knowledge to become specialists in the field, being able to achieve significant progress in their careers thanks to what they have learned. 

In this way, students will be able to learn in this program about issues such as Single Photon Emission Nuclear Medicine, infections and inflammations and the use of PET/CT-PET/MRI, all through an innovative teaching methodology 100% online based on the realization of practical cases, with which students will be able to combine their professional careers with their studies. 

Access the best Nuclear Medicine services thanks to your new expertise in adult pathology" 

This Postgraduate diploma in Nuclear Medicine in Adult Pathology contains the most complete and up-to-date educational program on the market. Its most notable features are:

• The development of case studies presented by experts in Nuclear Medicine.
• The graphic, schematic, and eminently practical contents with which they are created, provide scientific and practical information on the disciplines that are essential for professional practice.
• Practical exercises where the self-assessment process can be carried out to improve learning
• Its special emphasis on innovative methodologies
• Theoretical lessons, questions to the expert, debate forums on controversial topics, and individual reflection assignments
• Access to content from any fixed or portable device with an Internet connection

With this Postgraduate diploma you will be able to update your knowledge in Nuclear Medicine, keeping abreast of the latest advances in the field"

The program’s teaching staff includes professionals from the sector who contribute their work experience to this training program, as well as renowned specialists from leading societies and prestigious universities.  

The multimedia content, developed with the latest educational technology, will provide the professional with situated and contextual learning, i.e., a simulated environment that will provide immersive training programmed to train in real situations.  

This program is designed around Problem Based Learning, whereby the professional must try to solve the different professional practice situations that arise during the academic year. For this purpose, the student will be assisted by an innovative interactive video system created by renowned and experienced experts.

If you want to know the latest developments in Nuclear Medicine, this qualification will help you to achieve it. Enroll now"

Your reputation will increase when you are able to apply the basics of Nuclear Medicine to treat your adult patients"

This Postgraduate diploma in Nuclear Medicine in Adult Pathology  is composed of 3 modules through which students will be able to learn everything about Nuclear Medicine by single photon emission, PET/CT and PET/MR imaging diagnostic methods and PET gammagraphic studies and tracers applied to inflammation and infections. In this way, students will become true specialists in these subjects, and will be able to offer their patients all the techniques learned here immediately. 

These contents will make you a great specialist in Nuclear Medicine in Adult Pathology”

Module 1. Single Photon Emission Nuclear Medicine: “pearls and pitfalls”

1.1. Pneumology

1.1.1.  Perfusion/Ventilation 
1.1.2. Pulmonary Thromboembolism 
1.1.3.  Pulmonary Hypertension 
1.1.4. Lung Transplant 
1.1.5. Pleuroperitoneal Fistula: Cirrhotic Patient, Peritoneal Dialysis

1.2. Cardiology

1.2.1. Perfusion: Ischemic Heart Disease, Cellular Viability, Contribution  
1.2.2. GATED, Myocarditis 
1.2.3. Shunt: Left-Right, Right-Left 
1.2.4. Ventricular Function: Ischemic Cardiopathy, Cardiotoxicity 
1.2.5. Cardiac Innervation: Cardiac Pathology, Neurological Pathology

1.3. Vascular and Lymphatic System

1.3.1. Peripheral Endothelial Function 
1.3.2. Lower Limb Perfusion 
1.3.3. Lymphogrammagraphy

1.4. Osteoarticular

1.4.1. Primary Benign and Malignant Tumor Pathology: Planar Imaging 
1.4.2. Hybrid Image Contribution 
1.4.3. Bone Metastasis: Contributions of SPECT and SPECT/CT, Usefulness in Diagnosis and Monitoring 
1.4.4. Benign Pathology: Metabolic Disease, Sports Pathology

1.5. Nephrourology

1.5.1. Assessment of Renal Malformations 
1.5.2. Obstructive Pathology: Hydronephrosis in Pediatric Age: Diagnosis and Monitoring, Adult Hydronephrosis, Urinary Diversion Study 
1.5.3. Pyelonephritis: Initial Diagnosis, Evolution 
1.5.4. Renal Transplantation: Rejection, Tubular Necrosis, Nephrotoxicity, Urinary Leakage 
1.5.5.  Vasculorenal Hypertension: Diagnosis, Monitoring 
1.5.6. Glomerular Filtration and Effective Renal Plasma Flow 
1.5.7. Cystogammagraphy: Direct and Indirect in the Diagnosis and Monitoring of Vesicoureteral Reflux

1.6. Gastroenterology

1.6.1. Salivary Glands: Autoimmune Pathology, Post-radiation Damage, Salivary Gland Tumors
1.6.2. Digestive Transit: Esophageal Transit, Gastroesophageal Reflux, Pulmonary Aspiration, Gastric Emptying
1.6.3. Gastrointestinal Bleeding: Study with Labeled Red Blood Cells, Study with Radiocolloids
1.6.4. Hepatobiliary Pathology: Aliasic Cholecystitis, Hepatic Functional Reserve Assessment, Hepatic Transplantation ( Rejection, Biliary Leakage), Biliary Tract Atresia 
1.6.5. Bile Acid Malabsorption  
1.6.6. Inflammatory Bowel Disease: Diagnosis, Monitoring and Complications  
1.6.7. Hepatic Space-Occupying Lesion: Hepatic Hemangioma, Focal Nodular Hyperplasia vs. Adenoma 
1.6.8. Cell Labeling: Method and Indications 
1.6.9. Red Blood Cells: In Vivo, In Vitro, In Vivitro 
1.6.10. Leukocytes

1.7. Splenic Pathology

1.7.1. Hepatic Space-Occupying Lesions: Hemangioma, Hamartoma  
1.7.2. Splenosis: Study with Denatured Labeled Red Cells 
1.7.3. Cell Hijacking

1.8. Endocrinology 

1.8.1. Thyroid: Hyperfunctioning Thyroid ( Autoimmune, Thyroiditis), Thyroid Nodule, Differentiated Thyroid Carcinoma 
1.8.2. Parathyroid: Hyperfunctioning Gland Location  
1.8.3. Adrenal Glands: Adrenal Cortex Pathology (Hypercortisolism, Hyperaldosteronism), Adrenal Medulla Pathology (Hyperplasia, Pheochromocytoma), Adrenal Incidentaloma

1.9. Neurology SPECT vs. PET:

1.9.1. Cognitive Impairment: Characteristic Patterns and Differential Diagnosis  
1.9.2. Movement Disorders: Parkinson's Disease, Parkinson Plus and Differential Diagnosis
1.9.3. Epilepsy: Preoperative Assessment, Acquisition Protocols

1.10. Oncology: Tumor Viability, Radionecrosis vs. Progression

1.10.1. Brain Death
1.10.2. Cerebrospinal Fluid (CSF)-Cysternogammography Kinetics: Hydrocephalus, CSF Leakage

Module 2. Infection/Inflammation: Gammagraphic Studies and PET Tracers

2.1. Osteoarticular

2.1.1. Osteomyelitis: Previously Healthy Bone, Diabetic Patient, Spine Surgery
2.1.2. Prosthesis: Septic vs. Aseptic Mobilization

2.2. Cardiac

2.2.1. Endocarditis: Native Valve, Prosthetic Valve 
2.2.2. Myocarditis: Infectious vs. Inflammatory 
2.2.3. Intracardiac Devices

2.3. Vascular

2.3.1. Inflammatory Vasculitis
2.3.2. Prosthetic Graft Infection

2.4. Encephalitis: PET-FDG Study

2.4.1. Paraneoplastic
2.4.2. Infectious: Patterns and Differential Diagnosis

2.5. Fever of Unknown Origin

2.5.1. Immunosuppressed Patients
2.5.2. Postoperative Fever and Recurrent Sepsis

2.6. Systemic Disease

2.6.1. Sarcoidosis: Diagnosis, Extent and Response to Treatment  
2.6.2. IgG4-related Disease

2.7. Other Locations

2.7.1.  Hepatorenal Polycystic Kidney Disease: Localization of the Infectious Focus 
2.7.2. Hepatobiliary: Post-surgical Patient

2.8. Covid-19

2.8.1. Nuclear Medicine Studies in Acute Phase: Pulmonary Inflammation, Pulmonary Thromboembolism, Oncology Patient and Covid-19 
2.8.2. Utility of Nuclear Medicine in Postcovid Pathology: Pulmonary, Systemic 
2.8.3. Organizational Changes in a Pandemic Situation

Module 3. PET/CT- PET/MRI in Oncology Clinical Guidelines

3.1. Nuclear Medicine in Different Tumors

3.1.1. Staging and Prognosis
3.1.2. Response to Treatment
3.1.3. Monitoring and Diagnosis of Recurrence

3.2. Lymphomas

3.2.1.  Hodking's Lymphoma 
3.2.2. Diffuse Large B-cell Lymphoma 
3.2.3. Other Lymphomas

3.3. Breast Cancer

3.3.1. Initial Staging 
3.3.2. Response to Neoadjuvant 
3.3.3. Monitoring

3.4. Gynecologic Tumors

3.4.1. Vagina Cervix: Staging, Response to Treatment and Monitoring 
3.4.2. Endometrium: Staging, Response to Treatment and Monitoring 
3.4.3. Ovaries: Staging, Response to Treatment and Monitoring

3.5. Lung Cancer

3.5.1.  Non-small Cell Lung Carcinoma 
3.5.2. Small Cell Lung Carcinoma
3.5.3. Response Assessment: Radiotherapy, Immunotherapy

3.6. Digestive System Tumors

3.6.1. Esophago-Gastric
3.6.2. Colorectal
3.6.3. Pancreas
3.6.4. Hepatobiliary: Hepatocarcinoma, Cholangiocarcinoma

3.7. Sarcomas

3.7.1. Bones
3.7.2. Soft Parts

3.8. Urogenitals

3.8.1. Prostate
3.8.2. Renal 
3.8.3. Bladder 
3.8.4. Testicle 

3.9. Endocrine

3.9.1. Thyroid 
3.9.2. Adrenal Gland

3.10. Radiotherapy Planning

3.10.1. Acquisition of Exploration 
3.10.2. Volume Delimitation

The most innovative contents in adult pathology and Nuclear Medicine are here"